Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United State…
$71.05-12.76%
报价 2026-11-06
市值
$9.54B
EV
$11.39B
PE (TTM)
21.9x
预期 PE (FY2026)
14.2x
52 周区间距高点 -26.6%
$71.05$96.82
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 4.97 → 5.39（1.1x） | 13.2 |
| FY+32028-12 | 1.1x | 4.97 → 5.87（1.2x） | 12.1 |
毛利率 67% · TTM 收入 $3140M · 基数 EPS 4.97（调整后）
电话会信号
辅助标签Q3 20262026-11-05
积压订单词频高下调/撤回指引
指引 下调
信心 3
分析师 2
“New products SCRIPT, XLIF Prone, and EIQ are expected to drive meaningful growth in 2027 and beyond.”
原文引用（1）
- 下调/撤回指引：adjusting its full year 2026 revenue guidance downward to $3.09 billion compared to our previous guidance of $3.18 billion to $3.22 billion
蓝色标签在暴涨研究中略有区分度；悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| GMEDGlobus Medical, Inc. | $9.54B | -12.8% | +9.9% | 67.4% | 21.9x | 13.9x | 16.5x | |
| PENPenumbra, Inc. | $12.58B | -0.6% | +15.2% | 67.1% | 74.0x | 59.0x | 71.8x | |
| DVADaVita Inc. | $12.04B | -1.8% | +4.8% | 30.9% | 17.5x | 9.3x | 11.8x | |
| ALGNAlign Technology, Inc. | $11.79B | +4.2% | +2.7% | 68.7% | 24.1x | 14.5x | 16.7x | |
| MOHMolina Healthcare, Inc. | $10.91B | -3.5% | -0.6% | 8.2% | – | 31.2x | 45.8x | |
| BIOBio-Rad Laboratories, Inc. | $10.25B | +3.4% | +0.1% | 51.9% | 9.4x | 9.6x | 27.2x | |
| HSICHenry Schein, Inc. | $9.59B | +0.9% | +5.8% | 31.8% | 24.9x | 12.7x | 17.8x | |
| ATRAptarGroup, Inc. | $9.03B | -1.1% | +8.7% | 27.8% | 22.0x | 11.1x | 25.3x | |
| HQYHealthEquity, Inc. | $8.57B | +0.2% | +7.6% | 69.5% | 32.7x | 23.7x | 19.7x | |
| 同行中位数 | – | – | +5.3% | 41.9% | 24.1x | 13.6x | 22.5x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。